skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Evaluation of patient care interventions and recommendations by a transitional care pharmacist

(2264) Views  (497) Full article downloads

Authors: K Bruce Bayley, Lucy A Savitz, Teresa Maddalone, Stephen E Stoner, Jacquelyn S Hunt, Robert Wells

Published Date October 2007 Volume 2007:3(4) Pages 695 - 703
DOI: http://dx.doi.org/10.2147/TCRM.S

K Bruce Bayley1, Lucy A Savitz2, Teresa Maddalone3, Stephen E Stoner4, Jacquelyn S Hunt5, Robert Wells6

1Center for Outcomes Research and Education, Providence Health and Services, Portland, Oregon, USA; 2Abt Associates, Durham, North Carolina, USA; 3Providence Physician Division, Providence Health and Services, Portland, Oregon, USA; 4Regional Clinical Pharmacy Services, Providence Health and Services, Portland, Oregon, USA; 5Providence Physician Group, Providence Health and Services, Portland, Oregon, USA; 6Providence Portland Medical Center, Providence Health and Services, Portland, Oregon, USA

Abstract: A “transitional care pharmacist” (TCP) was deployed within an acute care setting to identify opportunities for improved continuity of care. The provision of medication reconciliation services, drug consultation, patient counseling and planning for after-hospital care was time consuming but also fruitful, resulting in roughly nine interventions per patient. Areas with the greatest potential for morbidity reduction were the resumption of home medications during the acute stay and at discharge. Allergy identification was a key contribution at admission, as was the provision of a detailed follow-up plan at discharge. Targeting high-risk patients and spreading portions of the work to other disciplines could achieve added efficiency in this service. Results have value to hospitals implementing medication reconciliation programs.

Keywords: patient safety, medication reconciliation, transitional care, pharmacist








Readers of this article also read:

Prevention of shingles: safety and efficacy of live zoster vaccine
Clinical studies with oral lipid based formulations of poorly soluble compounds
Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol
Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results
Using risk management files to identify and address causative factors associated with adverse events in pediatrics
A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
A pilot program at the worksite to reduce adverse self-medication behaviors
Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy
Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection